publication venue for Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies.. 26:785-792. 2015 Life-threatening dermatologic adverse events in oncology.. 25:225-234. 2014
